Insider · CIK 0001673237
Grant Julie Papanek
Reports to the SEC for 2 companies · MILPITAS, CA
Transactions
50
Companies
2
Filings
9
CIK
0001673237
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2023-03-01 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$465K |
| 2023-02-01 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$507K |
| 2023-02-01 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$24K |
| 2023-01-03 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$354K |
| 2023-01-03 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$162K |
| 2022-12-08 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$96.2K |
| 2022-12-02 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$108K |
| 2022-12-01 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$5,361 |
| 2022-12-01 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$103K |
| 2022-11-02 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$100K |
| 2022-11-01 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$100K |
| 2022-10-04 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$100K |
| 2022-10-03 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$100K |
| 2022-09-21 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$118K |
| 2022-09-21 | DAWNDay One Biopharmaceuticals, Inc.J Other | — |
| 2022-09-21 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$11.3M |
| 2022-09-20 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$2.85M |
| 2022-09-20 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$45.5K |
| 2022-09-19 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$1.58M |
| 2022-09-16 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$2.4M |
| 2022-09-16 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$82K |
| 2022-09-15 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$1.09M |
| 2022-09-15 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$78.6K |
| 2022-09-14 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$9,327.36 |
| 2022-09-14 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$2.5M |
| 2022-09-13 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$25.1K |
| 2022-09-13 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$2.11M |
| 2022-09-02 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$119K |
| 2022-09-01 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$104K |
| 2022-09-01 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$12.6K |
| 2022-08-05 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$100K |
| 2022-08-04 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$100K |
| 2022-07-18 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$52K |
| 2022-07-08 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$24.8K |
| 2022-07-05 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$16K |
| 2022-07-05 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$16K |
| 2022-07-01 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$20K |
| 2022-07-01 | DAWNDay One Biopharmaceuticals, Inc.S Sale | −$20K |
| 2022-06-21 | DAWNDay One Biopharmaceuticals, Inc. · Director Stock Option (Right to buy Common Stock)A Award | — |
| 2021-11-03 | DAWNDay One Biopharmaceuticals, Inc.G Gift | — |
| 2021-11-03 | DAWNDay One Biopharmaceuticals, Inc.G Gift | — |
| 2021-06-01 | DAWNDay One Biopharmaceuticals, Inc. · Series A Preferred StockC Conversion | — |
| 2021-06-01 | DAWNDay One Biopharmaceuticals, Inc.C Conversion | — |
| 2021-06-01 | DAWNDay One Biopharmaceuticals, Inc.P Purchase | +$208K |
| 2021-06-01 | DAWNDay One Biopharmaceuticals, Inc. · Series B Preferred StockC Conversion | — |
| 2021-06-01 | DAWNDay One Biopharmaceuticals, Inc.C Conversion | — |
| 2021-05-26 | DAWNDay One Biopharmaceuticals, Inc. · Stock Option (right to buy Common Stock)A Award | — |
| 2021-02-01 | DAWNDay One Biopharmaceuticals, Inc. · Series B Preferred StockA Award | — |
| 2017-05-25 | PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award | — |
| 2016-09-13 | PTGXProtagonist Therapeutics, Inc · Stock Option (right to buy)A Award | — |
Recent filings
- 4Grant Julie Papanek0001209191-23-015850SEC(opens sec.gov)
- 4Grant Julie Papanek0001209191-23-006945SEC(opens sec.gov)
- 4Grant Julie Papanek0001209191-23-001275SEC(opens sec.gov)
- 4Grant Julie Papanek0001209191-22-060728SEC(opens sec.gov)
- 4Grant Julie Papanek0001209191-22-059727SEC(opens sec.gov)
- 4Grant Julie Papanek0001209191-22-055596SEC(opens sec.gov)
- 4Grant Julie Papanek0001209191-22-052756SEC(opens sec.gov)
- 4Grant Julie Papanek0000899243-22-031691SEC(opens sec.gov)
- 4Grant Julie Papanek0000899243-22-031605SEC(opens sec.gov)
Companies
Address
C/O PROTAGONIST THERAPEUTICS, INC. 521 COTTONWOOD DRIVE, SUITE 100
MILPITAS, CA, 95035